MAPK1 and Cognitive impairment: Intracerebroventricular injection of corticotropin-releasing hormone in mice increased pMAPK1 in hippocampal CA1-CA3 areas [68], while it reduced pMAPK (P38 and ERK) levels in rats which improved cognitive impairment [69].